Taranabant
id:
taranabant-184-5542697
title:
Taranabant
text:
Taranabant is a cannabinoid receptor type 1 (CB1) inverse agonist that was investigated as a potential treatment for obesity due to its anorectic effects. It was discovered by Merck & Co. In October 2008, Merck has stopped its phase III clinical trials with the drugs due to high level of central nervous system side effects, mainly depression and anxiety.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Taranabant
date created:
2008-03-29T14:44:47Z
date modified:
2024-09-07T17:45:29Z
main entity:
{"identifier":"Q7685387","url":"https://www.wikidata.org/entity/Q7685387"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/fa/Taranabant_3D_spacefill.png","width":2000,"height":1143}
fields total:
13
integrity:
16